These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3927793

  • 1. Naloxone and TRH in the treatment of shock and trauma: what future roles?
    Bernton EW.
    Ann Emerg Med; 1985 Aug; 14(8):729-35. PubMed ID: 3927793
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Opiate antagonist in traumatic shock.
    McIntosh TK, Faden AI.
    Ann Emerg Med; 1986 Dec; 15(12):1462-5. PubMed ID: 3022620
    [Abstract] [Full Text] [Related]

  • 4. Thyrotropin releasing hormone: effects in monkeys and dogs subjected to experimental circulatory shock.
    Gurll NJ, Holaday JW, Reynolds DG, Ganes E.
    Crit Care Med; 1987 Jun; 15(6):574-81. PubMed ID: 3105962
    [Abstract] [Full Text] [Related]

  • 5. Opiate antagonists in shock and trauma.
    Holaday JW.
    Am J Emerg Med; 1984 Jan; 2(1):8-12. PubMed ID: 6097276
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cardiovascular effects of endogenous opiate systems.
    Holaday JW.
    Annu Rev Pharmacol Toxicol; 1983 Jan; 23():541-94. PubMed ID: 6307129
    [No Abstract] [Full Text] [Related]

  • 8. Endogenous opioid peptides: critical care implications.
    Zaloga GP, Hostinsky C, Chernow B.
    Heart Lung; 1984 Jul; 13(4):421-30. PubMed ID: 6330001
    [Abstract] [Full Text] [Related]

  • 9. Thyrotropin releasing hormone improves blood pressure and survival in endotoxic shock.
    Holaday JW, Ruvio BA, Faden AI.
    Eur J Pharmacol; 1981 Aug 27; 74(1):101-5. PubMed ID: 6797829
    [Abstract] [Full Text] [Related]

  • 10. Opioids and neuropeptides: mechanisms in circulatory shock.
    Bernton EW, Long JB, Holaday JW.
    Fed Proc; 1985 Feb 27; 44(2):290-9. PubMed ID: 3917942
    [Abstract] [Full Text] [Related]

  • 11. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N.
    Adv Shock Res; 1983 Feb 27; 10():63-71. PubMed ID: 6308974
    [Abstract] [Full Text] [Related]

  • 12. Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone.
    Feuerstein G, Lux WE, Snyder F, Ezra D, Faden AI.
    Circ Shock; 1984 Feb 27; 13(3):255-60. PubMed ID: 6432359
    [Abstract] [Full Text] [Related]

  • 13. Experimental endotoxin shock: the pathophysiologic function of endorphins and treatment with opiate antagonists.
    Faden AI, Holaday JW.
    J Infect Dis; 1980 Aug 27; 142(2):229-38. PubMed ID: 6251139
    [Abstract] [Full Text] [Related]

  • 14. Pressor effect of naloxone in septic shock.
    Peters WP, Johnson MW, Friedman PA, Mitch WE.
    Lancet; 1981 Mar 07; 1(8219):529-32. PubMed ID: 6111636
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alteration of leukotriene D4 hypotension by thyrotropin releasing hormone.
    Lux WE, Feuerstein G, Faden AI.
    Nature; 1983 Apr 28; 302(5911):822-4. PubMed ID: 6405279
    [Abstract] [Full Text] [Related]

  • 17. Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone.
    Faden AI, Hallenbeck JM, Brown CQ.
    Neurology; 1982 Oct 28; 32(10):1083-7. PubMed ID: 6811967
    [Abstract] [Full Text] [Related]

  • 18. Comparison of thyrotropin-releasing hormone (TRH), naloxone, and dexamethasone treatments in experimental spinal injury.
    Faden AI, Jacobs TP, Smith MT, Holaday JW.
    Neurology; 1983 Jun 28; 33(6):673-8. PubMed ID: 6405303
    [Abstract] [Full Text] [Related]

  • 19. Beneficial effect of the nonselective opiate antagonist naloxone hydrochloride and the thyrotropin-releasing hormone (TRH) analog YM-14673 on long-term neurobehavioral outcome following experimental brain injury in the rat.
    McIntosh TK, Fernyak S, Hayes RL, Faden AI.
    J Neurotrauma; 1993 Jun 28; 10(4):373-84. PubMed ID: 8145261
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of thyrotropin releasing hormone as a therapeutic intervention for endotoxemia.
    Brackett DJ, Schaefer CF, Lerner MR, Holaday JW, Fagraeus L, Wilson MF.
    Regul Pept; 1990 Jul 30; 29(2-3):153-62. PubMed ID: 2120745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.